ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)
London-based health technology company Sava Technologies raised $36M in Series B funding led by Ascensia. The round brings total capital to $68M. Funds accelerate manufacturing scale-up for their wearable biosensor platform measuring molecules beneath skin.
Tap to vote and see what everyone thinks.
Summary by ByteBrief